September 24, 2017 2:51 AM ET

Healthcare Equipment and Supplies

Company Overview of SD BioSensor Inc.

Company Overview

SD BioSensor Inc. develops products and services for testing blood. Its products include HbA1c analyzer, cholesterol analyzer, and blood glucose monitor. The company is based in Suwon, South Korea. SD BioSensor Inc. is a subsidiary of Standard Diagnostics, Inc.

Digital Empire Building 980-3




South Korea


82 3 1300 0477


82 3 1300 0499

Key Executives for SD BioSensor Inc.

Chief Executive Officer and President
Age: 56
Compensation as of Fiscal Year 2017.

SD BioSensor Inc. Key Developments

SD Biosensor & FIND Announce Collaboration to Develop Combination Malaria-CRP Rapid Test

SD Biosensor Inc. and FIND announced a collaboration to develop a rapid diagnostic test (RDT) that can simultaneously detect malaria infection and C-reactive protein (CRP) in the blood. Such an RDT would facilitate better management of fever in low- and middle-income countries by offering health-care workers a single, low-cost test that can determine whether a febrile illness is caused by malaria parasites, bacterial infection or both. Over the past decade, the increased use of malaria RDTs has brought down the inappropriate use of antimalarial therapies by linking treatment to confirmed diagnosis. However, studies are now revealing that these tests may be inadvertently driving the over-use of antibiotics. Without a simple point-of-care test to determine whether an infection is bacterial, health providers may empirically prescribe antibiotics to patients with fever who test negative for malaria. In studies conducted in Malawi, Tanzania and Laos, patients with negative malaria RDT results had markedly higher odds of being unnecessarily prescribed antibiotics. Antibiotics are not appropriate for viral or parasitic infections. Incorrect use of antibiotics contributes to the spread of antimicrobial resistance, endangers patients' health when serious illnesses are incorrectly treated and may increase health-care costs, which are often borne by patients out of pocket. CRP is a biomarker associated with bacterial infection. Tests that measure levels of CRP in the blood are routinely used to guide treatment decisions in high-income countries. Recent data suggest that CRP may also be suitable for use in Southeast Asia, a low malaria transmission setting. A combination malaria and CRP test that could be used at the point of care would give clinicians in low- and middle-income countries the ability to use a similar evidence-based approach to care, especially in low-burden malaria settings, where CRP has been shown to effectively differentiate bacterial from non-bacterial infections. SD Biosensor and FIND's joint work will involve reagent development, prototype development and performance evaluation, with the intention of delivering a design-locked test in late 2017. The development of the test will be based on SD Biosensor's existing technologies.

Similar Private Companies By Industry

Company Name Region
3D Imaging & Simulations Corp. Asia
Across Co., Ltd. Asia
Acucera, Inc. Asia
Aeilab Ltd. Asia
AGBIO Diagnostics Co., Ltd Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SD BioSensor Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at